Sunday, December 29, 2013 2:15:44 PM
DND is undervalued IMO, if Bioassaygen is a $2M asset then the pps w/ 24M o/s should realistically be closer to .07 - .09 not even factoring in whatever Cinutri's value is.
However, knowing DND I doubt they will even bother to try and capitalize on this awareness though, I don't expect to hear from them until 2014 sometime...if were lucky....lol.
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM